Clinical trial
A Phase 3 Multi-Center Actual-Use Study on the Safety of CL 108 for the Treatment of Moderate to Severe Acute Pain Associated With Osteoarthritis of the Knee or Hip
NCT02462850 is registered in ClinicalTrials.gov with Charleston Laboratories, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3 Multi-Center Actual-Use Study on the Safety of CL 108 for the Treatment of Moderate to Severe Acute Pain Associated With Osteoarthritis of the Knee or Hip
- Lead sponsor
- Charleston Laboratories, Inc
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2014
- Completion date
- February 28, 2015
- Enrollment
- 178 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.